Chemical Compound

Cucurbitacin A

CAS Registry Number 6040-19-3
Cucurbitacin A chemical structure
Primary Record

Cucurbitacin A

Note: Only for scientific research or as raw materials for production.

In stock
1,630 g
Purity
99.0 %
CAS
6040-19-3

Compound Identifiers & Properties

CAS
6040-19-3
PubChem CID
5281315
SMILES
CC(=O)OC(C)(C)/C=C/C(=O)[C@@](C)([C@H]1[C@@H](C[C@@]2([C@@]1(CC(=O)[C@@]3([C@H]2CC=C4[C@H]3C[C@@H](C(=O)C4(C)C)O)CO)C)C)O)O
Canonical SMILES
CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C[C@H](O)C(=O)C4(C)C)[C@]3(CO)C(=O)C[C@]12C

Names & Synonyms

  • Cucurbitacin A
  • Cucurbitacine A
  • CucurbitacinA
  • 6040-19-3
  • AC1NQYBS
  • RefChem:128712
  • UNII-83859MTO77
  • NSC 94743
  • NSC94743
  • NSC-94743
  • CHEBI:3940
  • CHEMBL455518
  • orb1684677
  • 83859MTO77
  • C32H46O9
  • Cucurbitacine A; NSC 94743
  • SCHEMBL10307352
  • DTXSID801317236
  • GAA04019
  • HY-N4175
  • ZINC4097796
  • 9169AF
  • LMST01010103
  • NP7089
  • AKOS040760353
  • ACN-057252
  • C32-H46-O9
  • CID5281315
  • FS-6973
  • J8.336D
  • DA-62530
  • LS-96986
  • CS-0032364
  • C08793
  • [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl] acetate
  • Q27106258
  • 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-(hydroxymethyl)-, (2beta,9beta,10alpha,16alpha,23E)-
  • 19-Norlanosta-5,23-diene-3,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-(hydroxymethyl)-, (2.beta.,9.beta.,10.alpha.,16.alpha.,23E)-
  • [(E,6R)-6-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(
  • 19-Norlanosta-5,11,22-trione, 2,16,20,25-tetrahydroxy-9-(hydroxymethyl)-, 25-acetate
  • ((E,6R)-6-((2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta(a)phenanthren-17-yl)-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl) acetate
  • (10alpha,23E)-25-(Acetyloxy)-2beta,16alpha,20-trihydroxy-9beta-(hydroxymethyl)-19-norlanosta-5,23-diene-3,11,22-trione
  • (2S,4R,23E)-2,16alpha,20-Trihydroxy-9alpha-(hydroxymethyl)-10,14-dimethyl-1,11,22-trioxo-8beta-4,9-cyclo-9,10-secocholesta-5,23-dien-25-yl acetate
  • (3E,6R)-6-[(1R,2R,3aS,3bS,8S,9aR,9bR,11aR)-2,8-dihydroxy-9b-(hydroxymethyl)-3a,6,6,11a-tetramethyl-7,10-dioxo-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-6-hydroxy-2-methyl-5-oxohept-3-en-2-yl acetate
  • [(E,5R)-5-[(2S,8S,9R,10R,13R,14S,16R,17R)-2,16-dihydroxy-9-(hydroxymethyl)-4,4,13,14-tetramethyl-3,11-dioxo-2,7,8,10,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-5-hydroxy-1,1-dimethyl-4-oxo-hex-2-enyl] acetate
  • 19-Nor-9.beta.,23-diene-3,11,22-trione, 2.beta.,16.alpha.,20,25-tetrahydroxy-9-(hydroxymethyl)-,25-acetate, (E)-
  • 19-Norlanosta-5,11,22-trione, 25-(acetyloxy)-2,16,20-trihydroxy-9-(hydroxymethyl)-,(2.beta.,9.beta.,10.alpha.,16.alpha.,23E)-